Jeff A. Baehr

Founder & CEO

In 2023, Jeff established Praxis Rock Advisors with the objective of helping funds and corporates in adopting the sophisticated technologies that have been integral to his successful career. Concurrently, he holds the position of Founder and CEO at RueOne Investments, an innovative independent private equity sponsor.

With over 20 years of experience as a principal investor, entrepreneur, and investment banker, Jeff has been involved in more than 50 transactions across multiple industries. He and his team have raised over $500 million for various funds and companies including his own. Jeff has effectively used technology throughout his career including managing a quantitative hedge fund, sourcing proprietary platforms & add-ons, successfully raising capital for funds and corporates, and helping his portfolio companies sell products and services.

In 2016, Jeff founded RueOne, a private equity sponsor transforming how family offices and institutional LPs access direct/co-investments. Before RueOne, he established Empiric Asset Management, a market-neutral hedge fund that outperformed indices and raised over $150 million in capital. Jeff started his career at The Carlyle Group, later taking on roles at Deutsche Bank, The World Bank, and ARIS Capital Management. His career reflects his deep understanding of finance, investment strategies, fundraising and the role of technology in the finance industry.

Stephen Frangione

Managing Director

Stephen Frangione heads the healthcare practice for Praxis Rock Advisors. He is an accomplished financial professional with over 25 years in institutional capital markets.

Concurrent to his role at Praxis Rock, Stephen is a partner and COO of RueOne Investments. He guides the firm's investment strategies, advisory & consulting services, and has attracted significant capital for emerging growth healthcare companies. 

Prior to joining RueOne, Stephen held the position of Managing Director at the Royal Bank of Scotland for six years. During his tenure, he developed and led the U.S. Investor Products and Equity Derivatives division, managing a group of 20 derivative professionals. He facilitated significant capital raises for global corporates, generated investment P&L, and managed relationships with large sophisticated institutional investors. 

Stephen also previously worked at Bank of America Securities, LLC in a similar capacity, with emphasis on debt/equity cross-asset solutions for corporates and investors. During his nine years as a Senior Vice President at J.P. Morgan Securities, Inc., he managed the equity-linked and convertible securities business.

Stephen started his career as a consultant at Coopers & Lybrand, honing his strategic skills. He holds an MBA from Northwestern University’s Kellogg School of Management and a BA in Economics from Amherst College. Further adding to his credentials, he holds the FINRA Series 7, 63, 9, 10, and 24 designations.

Stephen's track record in both the financial and healthcare sectors showcases his overall commitment to helping companies of all sizes secure valuable capital needed for growth.